350 related articles for article (PubMed ID: 16855800)
1. Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
Wang X; Olmsted-Davis E; Davis A; Liu S; Li Z; Yang J; Brunicardi FC
World J Surg; 2006 Aug; 30(8):1543-52. PubMed ID: 16855800
[TBL] [Abstract][Full Text] [Related]
2. Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice.
Liu SH; Smyth-Templeton N; Davis AR; Davis EA; Ballian N; Li M; Liu H; Fisher W; Brunicardi FC
Surgery; 2011 Apr; 149(4):484-95. PubMed ID: 21295812
[TBL] [Abstract][Full Text] [Related]
3. The effect of promoter strength in adenoviral vectors in hyperplastic synovium.
Goossens PH; Schouten GJ; Heemskerk B; 't Hart BA; Bout A; Kluin PM; Breedveld FC; Valerio D; Huizinga TW
Clin Exp Rheumatol; 2000; 18(5):547-52. PubMed ID: 11072592
[TBL] [Abstract][Full Text] [Related]
4. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
5. Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase gene directed by the rat insulin promoter.
Wang XP; Yazawa K; Yang J; Kohn D; Fisher WE; Brunicardi FC
J Gastrointest Surg; 2004 Jan; 8(1):98-108; discussion 106-8. PubMed ID: 14746841
[TBL] [Abstract][Full Text] [Related]
6. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
7. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
[TBL] [Abstract][Full Text] [Related]
8. Intravenous delivery of liposome-mediated nonviral DNA is less toxic than intraperitoneal delivery in mice.
Wang XP; Yazawa K; Templeton NS; Yang J; Liu S; Li Z; Li M; Yao Q; Chen C; Brunicardi FC
World J Surg; 2005 Mar; 29(3):339-43. PubMed ID: 15706434
[TBL] [Abstract][Full Text] [Related]
9. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral transfection of isolated pancreatic islets: a study of programmed cell death (apoptosis) and islet function.
Weber M; Deng S; Kucher T; Shaked A; Ketchum RJ; Brayman KL
J Surg Res; 1997 Apr; 69(1):23-32. PubMed ID: 9202642
[TBL] [Abstract][Full Text] [Related]
11. Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo.
Wang AY; Peng PD; Ehrhardt A; Storm TA; Kay MA
Hum Gene Ther; 2004 Apr; 15(4):405-13. PubMed ID: 15053865
[TBL] [Abstract][Full Text] [Related]
12. Recombinant fowlpox virus for in vitro gene delivery to pancreatic islet tissue.
Solomon MF; Ramshaw IA; Simeonovic CJ
Immunol Cell Biol; 2005 Dec; 83(6):615-25. PubMed ID: 16266313
[TBL] [Abstract][Full Text] [Related]
13. Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors.
Chu D; Sullivan CC; Weitzman MD; Du L; Wolf PL; Jamieson SW; Thistlethwaite PA
J Thorac Cardiovasc Surg; 2003 Sep; 126(3):671-9. PubMed ID: 14502138
[TBL] [Abstract][Full Text] [Related]
14. Intraocular adenoviral vector-mediated gene transfer in proliferative retinopathies.
Mori K; Gehlbach P; Ando A; Wahlin K; Gunther V; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1610-5. PubMed ID: 11980881
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector.
Arbuthnot PB; Bralet MP; Le Jossic C; Dedieu JF; Perricaudet M; Bréchot C; Ferry N
Hum Gene Ther; 1996 Aug; 7(13):1503-14. PubMed ID: 8864751
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer to the thymus. A means of abrogating the immune response to recombinant adenovirus.
DeMatteo RP; Raper SE; Ahn M; Fisher KJ; Burke C; Radu A; Widera G; Claytor BR; Barker CF; Markmann JF
Ann Surg; 1995 Sep; 222(3):229-39; discussion 239-42. PubMed ID: 7677454
[TBL] [Abstract][Full Text] [Related]
17. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
Sung RS; Qin L; Bromberg JS
Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated virus vector mediated gene transfer to pancreatic beta cells.
Prasad KM; Yang Z; Bleich D; Nadler JL
Gene Ther; 2000 Sep; 7(18):1553-61. PubMed ID: 11021593
[TBL] [Abstract][Full Text] [Related]
19. Targeting type II and Clara cells for adenovirus-mediated gene transfer using the surfactant protein B promoter.
Strayer MS; Guttentag SH; Ballard PL
Am J Respir Cell Mol Biol; 1998 Jan; 18(1):1-11. PubMed ID: 9448040
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for intraperitoneally disseminated pancreatic cancers by Escherichia coli uracil phosphoribosiltransferase (UPRT) gene mediated by restricted replication-competent adenoviral vectors.
Oonuma M; Sunamura M; Motoi F; Fukuyama S; Shimamura H; Yamauchi J; Shibuya K; Egawa S; Hamada H; Takeda K; Matsuno S
Int J Cancer; 2002 Nov; 102(1):51-9. PubMed ID: 12353234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
